Наталия Дзеружинская - Психические и поведенческие расстройства при ВИЧ-инфекции и СПИДе - учебное пособие

10. Сервецький А.К. Клiнiко-психопатогiчна характеристика адаптацiйних розладiв ВIЛ-iнфiкованих пацiентiв. Автореф. Дисс....кандитата медичних наук. – К.: УНДI ССПН, 2008. – 16 с.

11. Филиппова О.В. Когнiтивнi та афективнi розлади у пацiентiв з опiоiдною залежнiстю, обтяженою ВIЛ-iнфiкцiею (дiагностика, клiнiка, лiкування) Автореф. Дисс…канд.. медичних наук. – К.: УНДI ССПН, 2012. – 20 с.

12. Adler M.W. ABC of AIDS. Development of the epidemic // Br. Med. J. – 1987. – Vol. 294. – P. 1083-1085.

13. American Psychiatric Association. AIDS policy: guidelines for inpatient psychiatric units. Am J Psychiatry 1992; 149: 722.

14. Anderson M. Virus infections of the nervous system // Brain’s Diseases of the Nervous System, 10th edn, ch.9. Oxford: Oxford University Press, 1993.

15. Angelini L., Zibordi F., Triulzi F. et al. Age-dependent neurologic manifestations of HIV infection in childhood // Neurol. Sci. – 2000. – Vol. 21. – P. 135–142.

16. Asare E.K., Glass J.D., Luthert P.J. et al. Neuronal pattern diferences in HIV-associated dementia // Neuropathol. Applied Neurobiol. – 1995. – Vol. 151. – P. 21.

17. Atkinson J.H., Heaton K.K., Patterson T.L. et al. Two-year prospective study of major depressive disorder in HIV-infected men // J. Afect. Dis. – 2008. – Vol. 108. – P. 225–234.

18. Ayd FS Jr, Janicak PG, Davis JM. Advances in pharmacotherapy of psychotic disorders II. The novel antipsychotics. In: Janicak PG, ed. Principles and practice of pychopharmacotherapy. Update Vol. 1, No. 5. Baltimore: Williams & Wilkins. 1997.

19. Baingana F, Thomas R and Comblain C (2005) HIV/AIDS and mental health. Health, Nutrition and Population discussion paper, World Bank. Free download from www.worldbank.org

20. Batki SL. Busiprone in drug users with AIDS or AIDS related complex. J Clin Psvchopharmacol 1990; 10(Suppl 3): 1115-1155.

21. Batki SL. Drug abuse, psychoactive disorders and AIDS: dual and triple diagnosis. West J Med 1990; 152: 547-552.

22. Becker J.T., Lopez O.L., Dew M.A., Aizenstein H.J. Prevalence of cognitive disorders as a function of age in HIV virus function // AIDS. – 2004. – Vol. 18, Suppl.1. – P. 511–518.

23. Bell J.E., Brettle R.P., Chiswick A., Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexual with AIDS. Efect on neocortical involvement // Brain. – 1998. – Vol. 121. – P. 2043–2052.

24. Bell J.E., Bussuttil A., Ironside J.W. et al. Human immuno-defciency virus and the brain: investigation of virus load and neuro-pathologic changes in pre-AIDS subjects // J. Infectious Diseases. – 1993. – Vol. 168. – P. 818–824.

25. Binder RL. AIDS antibody tests on inpatient psychiatric units. Am J Psychiatry 1987; 144:176-181.

26. Brew B.J. HIV Neurology. Oxford University Press, 2001. – P. 64–90.

27. Brew B.J., Pemberton L., Cunningham P. et al. Levels of HIV-1 RNA correlate with AIDS dementia // J. Infection Dis. – 1997. – Vol. 175. – P. 963–966.

28. Budka H. Neuropathology of human immunodefciency virus infection // Brain Pathology. – 1991. – Vol. 1. – P. 163–175.

29. Burch EA, Montoya J. NMS in an AIDS patient. J Clin Psychiatry 1989; 9: 228-229.

30. Carrico A.W., Johnson M.O., Morin S.F. et al. Correlates of suicidal ideation among HIV-positive persons // AIDS. – 2007. – Vol. 21. – P. 1199–1203.

31. Catalan J, Burgess A, Klimes I (1995). Psychological medicine of HIV infection. Oxford University Press, Oxford, UK.

32. Centre for Harm Reduction (2003). Manual for reducing drug-related harm in Asia. Melbourne, Australia. EuroHIV (2005).

33. Chang L., Ernst T., Leonido-Yee M. et al. Cerebral metabolites correlate with clinical severity of HIV-cognitive motor complex // Neurology. – 1999. – Vol. 52. – P. 100–108.

34. Childs E.A., Lyler R.H., Selnes O.A. et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy // Neurology. – 1999. – Vol. 52. – P. 607–613.

35. Cournos F, Empfeld M, Horwath E, Kramer M. The management of HIV infection in state psychiatric hospitals. Hosp Comm Psychiatry 1989; 40: 153-158.

36. Cummings J.L., Benson D.F. Dementia: A Clinical Approach, 2nd edition. London: Butterworths, 1992.

37. Davis JM, Janicak PG, Preskorn SH, Ayd F Jr. Advances in the psychopharmacotherapy of psychotic disorders. In: Janicak PG, ed. Principles and practice of psychopharmacotherapy. Update Vol. 1, No 1. Baltimore: Williams & Wilkins, 1994.

38. De Ronchi D., Faranca I., Forti P. et al. Development of acute psychotic disorders and HIV-1 infection // Int. J. Psychiatry Med. – 2000. – Vol. 30. – P. 173–183.

39. DiClemente RJ, Ponton LE. HIV-related risk behaviors among psychiatrically hospitalized adolescents and school-based adolescents. South J Psychiatry 1993; 150: 324-325.

40. Dunbar N., Brew B.J. Neuropsychological dysfunction in HIV infection: a review // J. NeuroAIDS. – 1996. – Vol. 1, № 3. – P. 73–102.

41. Einsiedel R.W. von, Berger T., Weisbrod M. et al. HIV-Patienten mit psychiatrischen Krankheiten. Behandlungsstrategien und Medikamenteninteraktionen // Nervenarzt. – 2001. – Vol. 72. – P. 204–215.

42. Feinberg T.E., Farah M.J. Behavioral neurology and neuropsychology. 2nd edition. Part 7. 2003. – Ch. 50. – P. 629–637.

43. Fernandez F, Adams F, Levy JK, et al. Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics 1988; 29: 38-46.

44. Fernandez F. Neuropsychiatric aspects of human immunodefciency virus (HIV) infection // Curr. Psychiatry Reports. – 2002. – Vol. 4. – P. 228–231.

45. Foster R., Olajide D., Everall I.P. Antiretroviral therapy-induced psychosis: case report and brief review of the literature // HIV Medicine. –2003. – Vol. 4. – P. 139–144.

46. Foster R., Taylor C., Everall I.P. More on abacavir-induced neuropsychiatric reactions // AIDS. – 2004. –Vol. 18. – P. 24–49.

47. Gilmer W, Busch K. Neuropsychiatric aspects of AIDS and psychopharmacologic management. Psychiatr Med 1991; 9: 313-329.

48. Haller D.L., Miles D.R. Suicidal ideation among psychiatric patients with HIV: psychiatric morbidity and quality of live // AIDS Behav. –2003. –Vol. 7. – P. 101–108.

49. Halman MH,Worth JL, Sanders KM, et al. Anticonvulsant use in the treatment of manic syndrome in patients with HIV-1 infection. J Neuropsychiatry Clin Neurosci 1993; 5: 430-434.

50. Hamers F. and Downs A. HIV in central and eastern Europe. The Lancet. – 2003. – Vol. 361. – Р. 1035-44, 22March.

51. Horwath E, Kramer M, Cournos F, et al. Clinical presentations of AIDS and HIV infection in state psychiatric facilities. Hosp Comm Psychiatry 1989; 40: 502-514.

52. Jacobsberg LB, Perry S. Medical management of AIDS patients: psychiatric disturbances. Med Clin North Am 1992; 76: 99-106.

53. Janicak PG. Psychopharmacotherapy in the HIV-infected patient. Psychiatric Ann 1995; 25 (10): 609-613.

54. Jobe ТН. Neuropsychiatry of HIV disease. In: Flaherty J, Davis JM, Janicak PG, eds. Psychiatry: diagnosis and therapy. New York: Appleton and Lange, 1993.

55. Justice A.C., McGinnis K.A., Atkinson J.H. et al. Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study // AIDS. – 2004. – Vol. 18, Suppl.1. – P. 49–59.

56. Kalichman S (1995). Understanding AIDS: A guide for mental health professionals. American Psychological Association. Washington DC, USA.